Marietta Investment Partners LLC Has $2.19 Million Stake in Lam Research Corporation $LRCX

Key Points

• Marietta Investment Partners boosted its stake in Lam Research by 45.6%, owning 16,379 shares valued at about $2.19 million at the end of the most recent reporting period.
• Lam Research beat Q results (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B), set Q3 2026 EPS guidance of $1.25–$1.45, and carries analyst price targets that imply roughly ~25% upside from current levels.
• Insider selling has been notable: CFO Douglas Bettinger sold 50,057 shares (~$11.2M) and insiders have disposed of about 130,886 shares (~$29.7M) in the past 90 days, a factor that could weigh on near-term sentiment.

Marietta Investment Partners LLC lifted its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 45.6% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,379 shares of the semiconductor company's stock after acquiring an additional 5,129 shares during the period. Marietta Investment Partners LLC's holdings in Lam Research were worth $2,193,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the second quarter valued at about $27,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research during the 2nd quarter worth approximately $29,000. Delos Wealth Advisors LLC bought a new position in Lam Research in the second quarter worth approximately $30,000. Country Trust Bank acquired a new stake in Lam Research in the second quarter valued at approximately $39,000. Finally, Sound Income Strategies LLC bought a new stake in shares of Lam Research during the third quarter valued at approximately $41,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Price Performance

Lam Research stock opened at $214.68 on Friday. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $256.68. The company's 50 day moving average price is $220.52 and its two-hundred day moving average price is $168.05. The stock has a market cap of $268.09 billion, a P/E ratio of 43.99, a P/E/G ratio of 2.40 and a beta of 1.77. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.10. The company had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.Lam Research's quarterly revenue was up 22.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Wednesday, March 4th. Lam Research's payout ratio is presently 21.31%.

Wall Street Analysts Forecast Growth

LRCX has been the topic of a number of recent research reports. Weiss Ratings reiterated a "buy (b)" rating on shares of Lam Research in a report on Monday, December 29th. Oppenheimer reaffirmed an "outperform" rating and issued a $265.00 price objective on shares of Lam Research in a research note on Thursday, January 29th. JPMorgan Chase & Co. boosted their target price on shares of Lam Research from $165.00 to $300.00 and gave the stock an "overweight" rating in a research report on Thursday, January 29th. Susquehanna set a $325.00 target price on shares of Lam Research and gave the stock a "positive" rating in a report on Thursday, January 29th. Finally, Evercore set a $275.00 price target on Lam Research in a research note on Thursday, January 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $245.19.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Wall Street analysts’ consensus price targets imply roughly 25% upside, signaling continued bullish expectations on earnings and multiple expansion that could support a recovery if macro fears ease. Wall Street Analysts Think Lam Research (LRCX) Could Surge 25.43%
• Positive Sentiment: Operationally constructive: Lam opened a Boise R&D/office to deepen collaboration with Micron, reinforcing its role in memory/AI supply chains — a structural growth angle for equipment demand. Lam Research Boise Expansion Deepens Ties To Micron And AI Memory Demand
• Positive Sentiment: Technical signals have flipped bullish in the short term: LRCX recently crossed above its 50‑day moving average and hit a key trading signal/intraday high — this can attract momentum traders on any stabilization. Lam Research (LRCX) Crossed Above the 50-Day Moving Average: What That Means for Investors
• Neutral Sentiment: Positive investor narratives remain (billionaire ownership interest, recent Argus price‑target increases and inclusion on some buy lists), but these are longer‑horizon supports rather than immediate catalysts. Here Is Why Lam Research (LRCX) Is Highly Favored By Billionaires
• Negative Sentiment: Large insider selling — including CFO Douglas Bettinger’s multi‑million dollar sale (50,057 shares) and other insider disposals — is weighing on sentiment and was specifically cited as a driver of recent weakness. Lam Research NASDAQ: LRCX CFO Sells $9,284,542.38 in Stock
• Negative Sentiment: Sector and macro risk: headlines about Middle East conflict, higher energy costs and potential supply‑chain/fab operating‑cost shocks (notably for South Korean fabs) triggered a memory/storage rout and raised concerns that customer capex economics could be squeezed — a direct negative for equipment demand outlook in the near term. Lam Research (LRCX) Is Down 10.6% After Fab Cost Concerns Linked To Geopolitics And Energy Prices

Insider Transactions at Lam Research

In related news, insider Ava Harter sold 1,500 shares of the business's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total value of $333,990.00. Following the transaction, the insider directly owned 53,205 shares of the company's stock, valued at approximately $11,846,625.30. The trade was a 2.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer owned 1,081,705 shares of the company's stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 130,886 shares of company stock worth $29,658,802 in the last ninety days. Company insiders own 0.31% of the company's stock.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.